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Abstract
Plants are a major source of nutrition and health care. Emblica officinalis (EO) is one of the most widely 
used in traditional Indian medicine in different forms and believed to alleviate against several diseases. 
This article summarizes the multipurpose and medicinal value of EO. I reviewed the application of EO 
in antioxidant, antidiabetic, anticancer, antiulcer, cardioprotective activity, cytoprotective, antitussive, 
immunomodualation, chelating agent, and respiratory problems.
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Introduction
Background
Plants have always been a major source of nutrition and 
health care for both humans and animals. The writings 
on nutritional and medicinal plants go way back to 
1500 B.C in Egypt, 800–400 B.C. in Indo-Pakistan, and 
500 B.C. in China. However, scientific research interest 
in medicinal plants received a thrust during the mid-
1970s when the World Health Organization proposed 
the incorporation of traditional medicine into the 
health-care system.[1] Among the many medicinal 
plants of research interest, Emblica officinalis (EO) is 
the one.
EO is a plant genus of the family Euphorbiaceae. It is 
also named as amla, Phyllanthus emblica, or Indian 
gooseberry. The species is native to India and also 
grows in tropical and subtropical regions including 
Pakistan, Uzbekistan, Sri Lanka, South East Asia, 
China, and Malaysia and also found in Burma.[2] It 
is a deciduous tree of small to medium size up to 
5.5 m with green-gray or red bark, peeling off scales, 
and long strips. The fruit is fleshly around 2.24 cm in 
diameter, 5.68 g in weight. Apart from the fruit, the 
leaves and bark are a good source of tannin.[3]
The fruit of EO is highly valued in traditional 
Indian medicine.[4] Thus, the dried fruits of amla 
are used to treat hemorrhage, diarrhea, and 
dysentery.[5] In addition, the fruit of EO is diuretic, 
hepatoprotective,[6,7] and antitumor.[8] Moreover, 
the fruits have potent antioxidant activity due to 
the presence of tannoids, tannins, Vitamin C, and 
flavonoids.[9] The pharmacological studies on EO have 
revealed that it has good antioxidant, cytoprotective, 
immunomodulatory, antidiabetic, hypolipidemic, 
and cardioprotective, antiulcerogenic.[10] EO has 
been widely consumed by humans for thousands of 
years, and it was found to be nontoxic to human and 
experimental animals.[11] No toxicity was observed in 
the toxicological results of the experimental models 
in the highest dose range.[12] The plant is very rich 
with different components [Table 1].
Preparations
The plant is used in many forms. One of the most 
popular is as a decoction and infusion of leaves and 
seeds. However, it is also used as liquor, a fixed, 
and an essential oil. It makes an astringent extract 
equal to catechu, which is prepared from the root 
by decoction and evaporation.[2]
Description of the plant
The green fruit is described as being exceedingly 
acid. The dried fruit is sour and astringent. The 
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flowers are cooling and aperients. The bark is 
astringent.[14] There are two forms of amla, the 
wild one with smaller fruits and the cultivated 
form sometimes called “Banarasi” with larger 
fruits.[3] The plant is widely distributed and 
habitat in Asia and also used in different forms 
[Table 2].
Chemical constituents
The fruit is a very rich source of Vitamin C. it is 
mineral and vitamin contents include calcium, 
phosphorous, iron, carotene, thiamine, riboflavin, 
and niacin. The seed of the Indian gooseberry 
contains a fixed oil, phosphatides, and an essential 
oil. The fruits bark and the leaves of this tree are 
rich in tannin.[15]
The root contains ellagic acid and lupeol and bark 
contains leucodelphinidin. It has the following fatty 
acids: Linolenic 8.8%, oleic 28.4%, stearic 2.15%, 
palmitic 3.0%, and myristic 1.0%.[3]
Table 1: Average percentage composition of 
the fruit pulp of Emblica officinalis[13]
S. No. Components Percentage
1 Moisture 81.2
2 Protein 0.5
3 Fat 0.1
4 Mineral matter 3.4
5 Fiber 0.7
6 Carbohydrate 14.1
7 Calcium 0.05
8 Phosphorous 0.02
9 Iron 1.2 mg/100 g
10 Nicotinic acid 0.2 mg/100 g
11 Vitamin C 600 mg/100 g
Table 2: General description of Emblica officinalis[14]
No. 1. Habitat
1 Found in India, Pakistan, Uzbekistan, Sri Lanka, South East Asia, China, and Malaysia
2. Used parts
1 Dried fruits, fresh fruit, seed, leaves, root bark, and flowers
3. Fruits
1
2
3
4
5
6
Ripen from November to February
Nearly spherical or globular, wider than long and with a small and slight conic depression on both apexes
Fruit is 18–25 mm wide and 15–20 mm long
Surface is smooth with six obscure vertical pointed furrow
Mesocarp is yellow and endocarp is yellowish-brown in ripened condition
In fresh fruit mesocarp is acidulous and in dried fruit, it is acidulous astringent
4. Leaves
1
2
Leaf is 8–10 mm or more long and 2–3 mm broad, hairless light green outside, pale green, or often 
pubescent beneath
It contains gallic acid, ellagic acid, chebulic acid, chebulinic acid, chebulagic acid, a gallantonic called amlic 
acid, alkaloids phyllantidine, and phyllantine
5. Seed
1 Four-six, smooth a fixed oil, phosphatides, and a small quantity of essential oil. The fixed oil yield 16% and 
has the following physical and chemical characteristics: Acid value 12.7; saponification value 185; iodine 
value 139.5; acetyl value 2.03; unsaponifiable matter 3.81%; sterol 2.70%; saturated fatty acid 7%. Contains 
linolenic acid (8.78%), linoleic (44%). oleic (28.40%), stearic (2.15%), palmitic (2.99%), and myristic acid 
(0.95%)
6. Barks
1
2
Thick to 12 mm, shining grayish-brown or grayish-green.
Leukodelphinidin, tannin, and proanthocyanidin
7. Roots
1 Ellagic acid and lupeol
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Therapeutic properties of EO
EO is a very rich source of Vitamin C, which is said to 
be the second-highest among all fruits.[19] The fruit, 
because of its high acidity and astringent taste, is not 
palatable for direct consumption but its excellent 
and therapeutic values offer enormous potentiality 
for processing.[20] Some of the therapeutic values 
are [Table 3]:
Antibacterial, antifungal, and antiviral
Medical studies conducted on amla fruit 
suggested that it has antiviral properties[21] and 
also functions as an antifungal agent.[22] EO has 
been reported for the antimicrobial activities.[16] 
The plant has been reported to possess potent 
antibacterial activity against Escherichia coli, 
Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Salmonella Paratyphi A, Salmonella Paratyphi B, 
and Serratia marcescens.[23]
Antioxidant
The origin of disease of multi-factorial nature is being 
understood due to the vitiation in basic hemostatic 
balance phenomenon in the body. It is increasingly 
being realized now that majorities of the disease are 
mainly to the imbalance between pro-oxidant and 
anti-oxidant in the body.[10] Pro-oxidant condition 
dominates either due to increased generation of 
free radicals and/or their poor scavenging into 
the body. Free radicals are fundamental to any 
biochemical process and they are continuously 
produced by the body’s normal use of oxygen such 
as respiration and some cell-mediated immune 
functions.[18] Free radicals play an important role 
in some pathogenesis of serious diseases such as 
cancer, neurodegenerative disorders, and cataracts; 
inflammation compounds that can scavenge free 
radicals have a great potential in ameliorating these 
disease.[4] It was reported that phenolic compounds 
in plants possess strong antioxidant activity and 
may help to protect cells against free radicals.[8]
Antidiabetic effect
Oral administration of the extracts (100 mg/kg 
body weight) reduced the blood sugar level within 
4 h. EO and an enriched fraction of its tannoids 
are effective in delaying development of diabetic 
cataract in rats.[24] Aldose reductase (AR) has its 
involvement in the development of secondary 
complications of diabetes including cataract. EO is 
proved as an important inhibitor of AR.[24]
Anticancer activity
EO inhibits the growth and spread of various cancers, 
including breast, uterus, pancreas, stomach and 
liver cancers, and malignant ascites. It reduces the 
side effects of chemotherapy and radiotherapy.[25] 
EO has been reported to possess many medicinal 
properties including immune-stimulator and 
antitumor activities.[8] It enhances natural killer cell 
activity in various tumors.[26] Chemoprevention with 
food phytochemicals is presently considered as one 
of the most important strategies to control cancer.[27]
Antiulcer activities
A herbomineral formulation of the Ayurveda 
medicine named Pepticare, composed of EO, was 
tested for its antiulcer and antioxidant activity in 
rats. Reports were made that Pepticare exhibit 
antiulcer activity, which can be attributed to its 
antioxidant property.[28] Methanolic extract of EO 
was studied against ulcer and its healing effects due 
to its defensive mucosal factors.[29]
Cardioprotective activity
The effects of chronic oral administration of fresh 
fruit homogenate of amla on myocardial antioxidant 
system and oxidative stress induced by ischemic-
reperfusion injury (IRI) were investigated on the 
heart in rats. Chronic EO administration produces 
myocardial adaptation by augmenting endogenous 
antioxidants and protects rat hearts from oxidative 
stress associated with IRI.[30]
Cytoprotective, antitussive, and gastroprotective 
activity
EO has been reported for its cytoprotective 
and immunomodulating properties against 
Table 3: The biological effect of  
Emblica officinalis
Biological effect References
Antimicrobial activity [16]
Antioxidant activity [7]
Enhancer of natural killer activity [17]
Anti-inflammatory activity [18]
Hypolipidemic [3]
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chromium (VI) induced oxidative damage. It 
inhibited chromium induced immunosuppressant 
by macrophages and phagocytosis.[31]
EO was tested for its antitussive activity in conscious cats 
by mechanical stimulation of the laryngopharyngeal 
and tracheobronchial mucous areas of airways.[32] It was 
then reported that amla extract exhibits antisecretory, 
cytoprotective, and antiulcer properties.[33]
Immunomodulation activity
Immune activation is an effective as well as 
protective approach against emerging infectious 
diseases. Oral administration of Triphala appears 
to stimulate the neutrophil functions in the 
immunized rats, and stress-induced suppression in 
the neutrophil functions was significantly prevented 
by Triphala.[34] EO fruits have been reported to be 
used for hepatoprotection in Ayurveda.[35]
Chelating agent
Photoaging of the skin is a complex biologic process 
affecting various layers of the skin with major changes 
seen in the connective tissue within the dermis. 
Emblica was shown to reduce ultraviolet-induced 
erythema and had excellent free-radical scavenging 
ability, chelating ability to iron, and copper.[15]
Diarrhea
It is used medicinally for the treatment of diarrhea. As 
a fruit decoction, it is mixed with sour milk and given by 
the natives in cases of dysentery.[36] The bark partakes 
of the astringency of the fruit. A decoction and 
evaporation of the root solution produce an astringent 
extract equal to catechu.[16] An infusion of the leaves 
with fenugreek seed is given for chronic diarrhea.[37]
Respiratory problems
The fresh fruit is used inflammations of lungs 
the expressed juice of the fruit along with other 
ingredients is used to cure cough, asthma.[37]
Alcohol
The general chemical formula for alcohol is 
CnH2n+1OH. Alcohol is a psychoactive drug that has 
a depressant effect. Alcohol is a moderately good 
solvent for many fatty substances and essential 
oils. This attribute facilitates the use of flavoring 
and coloring compounds in alcoholic beverages, 
especially distilled beverages.[38]
Alcoholism
Alcohol can be addictive, and the state of addiction 
to alcohol is known as alcoholism. Alcoholism can 
lead to malnutrition because it can alter digestion 
and the metabolism of most nutrients. Alcoholism 
is also associated with a type of dementia called 
Wernicke-Korsakoff syndrome, which is caused by a 
deficiency in thiamine (Vitamin B1). Muscle cramps, 
nausea, loss of appetite, nerve disorders, and 
depression are common symptoms of alcoholism.[39]
Effects of alcohol on health
Chronic excessive alcohol consumption is more 
prevalent all over the world and is associated with tissue 
and organ damage leading to coronary heart disease, 
alcohol liver disease, and several other manifestations, 
including neurological disorders for which therapeutic 
approaches are sought.[40] Enhanced oxidative stress 
and decreased antioxidant status induced by ethanol 
metabolism play a major role in the causation of alcohol 
toxicity and damage.[41] Chronic alcohol consumption 
has major effects on the absorption, elimination, 
and serum concentrations of many physiologically 
important electrolytes and minerals.[42]
Pathophysiology
Alcohol is metabolized by oxidative reactions to 
acetaldehyde and then converted to acetate through 
alcohol dehydrogenase (ADH) and acetaldehyde 
dehydrogenase (ALDH). ADH is quantitatively the 
most important enzyme capable of catalyzing the 
conversion of ethanol to acetaldehyde. Mechanisms 
implicated in alcohol-induced liver damage 
involve many biochemical reactions with different 
simultaneous pathways interacting with each 
other. These mechanisms involve enzymes, reactive 
oxygen species (ROS), endotoxins, cytokines, 
immune system cells, and genetic predisposition to 
develop alcoholic liver disease.[43]
Clinical Trails
Various studies have been done to examine the 
protective effects of EO against alcohol-induced 
oxidative stress. Most of these studies were done 
on animals using different doses of alcohol and EO. 
The length of the treatment period of most of the 
studies was also different in different groups.
In the study undertaken by Damodara Reddy,[44] 
the role of EO was investigated in the prevention 
of alcohol-induced hepatic injury. In this study, 
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2-month-old male albino Wistar rats, weighing 
about 120–140 g were used. The rats were 
randomly divided into four groups of eight rats in 
each group:
• Group I was the control group and received 
glucose instead of alcohol (i.e., caloric 
equivalent to alcohol)
• Group II was the alcohol-treated group, which 
received 20% (v/v) alcohol, at a dose of 5 g/kg 
body weight/day
• Group III was the alcohol plus EO treated group 
and was given 20% (v/v) alcohol (at a dose of 
5 g/kg body weight/day) plus aqueous EO fruit 
extract (EFE), at a dose of 250 mg/kg body 
weight/day
• Group IV – Animals in this group received only 
the aqueous EFE, at a dose of 250 mg/kg body 
weight/day and glucose (iso-caloric equivalent 
to ethanol).
The extract and alcohol were administered daily for 
60 days using an intragastric tube. Food and water 
intake of all the animals was recorded daily, and 
weight of the rats was measured on alternate days. 
At the end of the experimental period, the rats in 
each group were fasted overnight and then killed by 
cervical dislocation.
The liver tissues were dissected, weighed, and 
washed using ice-cold saline solution. Thiobarbituric 
acid reactive substances (TBARS) were measured by 
the formation of malondialdehyde. Protein carbonyls 
were determined using 2, 4-dinitrophenylhydrazine, 
and catalase (CAT), superoxide dismutase (SOD), 
glutathione peroxidase (GPx) and were assessed 
based on the ability of a compound to scavenge the 
free radical.
A portion of the median lobe of the liver was 
dissected and fixed in 10% neutral buffered 
formalin solution for 24 h. The fixed tissues were 
processed routinely and were then embedded in 
paraffin, sectioned to 3–5 µm thickness. The extent 
of alcohol-induced necrosis was evaluated by 
assessing morphological changes in liver sections 
stained with hematoxylin and eosin, using standard 
techniques. The statistical significance of the 
difference between control and treatment groups 
in this study was determined by ANOVA. The data 
were expressed as mean and standard deviation 
(SD). The level of significance chosen was P < 0.05.
The results of this study also revealed that the mean 
levels of TBARS, protein carbonyls, nitrite, and 
nitrate levels were found to be significantly higher in 
alcohol-treated rats compared to the control group 
(P < 0.05). Mean activities of antioxidant enzymes, 
namely, SOD, CAT, GPx, and glutathione (GSH) 
levels, were found to be significantly decreased in 
the alcohol-treated group compared to the control 
group.
The investigators explained the adverse changes 
that occurred in the alcohol-treated group were 
as being the results of increased formation of 
lipid peroxides and associated ROS-mediated 
liver damage. Moreover, the improvement in the 
EFE treated group is because of the presence of a 
considerable amount of tannoids and polyphenolic 
compounds which have a radical scavenging 
activity and inhibits the lipid and protein oxidation 
of alcohol. The researchers concluded that 
administration of EFE in alcohol-induced oxidative 
stressed rats, increased the activity of enzymatic 
antioxidant, inhibits the effect of lipid peroxidation 
by its free radical scavenging nature, and also 
improves the histomorphology of the liver near to 
normal.
As stated by Yokozawa,[45] 21 of male Wistar strain 
rats were 2 months old (young rats) weighing 125 g 
and aged rats 10 months old weighing 476 g were 
used. The animals were divided into three groups.
• Group 1 was the control group and received 
water alone
• Group 2 was the alcohol-treated group, which 
received at dose of 10 mg/kg body weight/day
• Group 3 was the sun amla extract-treated 
group and was given at a dose of 40 mg/kg 
body weight/day.
The animals in all of the groups were treated for 
100 days by gastric intubations. At 6 h after the 
last dose, all animals were decapitated to draw the 
blood. And they collected the serum and determined 
the levels of cholesterol, triacylglycerol (TAG), and 
peroxisome proliferator-activated receptor (PPAR) 
protein using commercial kit. They took liver, dried 
on tissue paper, weighed and stored at 80°C until 
analysis. Results were expressed as mean values 
with their standard errors (SE). The effect on each 
parameter was examined using one-way ANOVA. 
Individual differences between groups were 
evaluated. The level of significance chosen was 
P < 0.05.
The administration of amla significantly decreased 
the adverse effects of alcohol. The PPAR protein 
level in liver was reduced in aged alcohol-treated 
rats. The administration of amla significantly 
increased the hepatic PPAR protein level. The 
investigators explained the adverse changes that 
occurred in the alcohol-treated group were showed 
the total cholesterol and TAG levels in the serum of 
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aged rats (10 months old) were higher than those 
of young rats (2 months old). Administration of 
amla significantly decreased the adverse effect of 
alcohol in aged rats.
The researchers concluded that the age-related 
increases of lipids and oxidative stress were 
mediated by the reduction of hepatic PPAR protein 
expression. Administration of amla for 100 days to 
aged rats attenuates age-related dyslipidemia and 
oxidative stress by inhibiting increases in cholesterol 
and TAG levels in the serum and liver.
In another study by Reddy,[46] the protective effects 
of EO also were studied. Two-month-old male 
albino Wistar rats, weighing about 120–140 g were 
used. The animals were divided randomly into four 
groups each having eight members.
• Group I: Was the control group and received 
isocaloric amounts of glucose (18.6 g/kg of 
body weight/day), equal to that of alcohol
• Group II: Was the alcohol-treated group, which 
received 33% (v/v) alcohol at a dose of 10 g/kg 
of body weight/day.
• Group III: Was the alcohol plus EFE treated 
group and was given 33% (v/v) alcohol (at a 
dose of 10 g/kg of body weight/day) plus EFE, 
at a dose of 250 mg/kg of body weight/day
• Group IV: Animals in this group received only the 
EFE, at dose of 250 mg/kg of body weight/day.
The animals in all the groups were treated for 60 days 
by gastric intubations. Food and water intake of all 
the animals was recorded daily; and weight of the 
rats was measured on alternate days. At the end 
of the treatment, they took blood and determined 
the activities of aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), and alkaline 
phosphatase (ALP) using commercial kits. Liver 
tissues also were taken and determined the levels 
of SOD, GPx, reduced GSH, lipid peroxidation, and 
protein carbonyl content from freshly isolated 
mitochondria.
The results of this study also revealed that the 
mean levels of antioxidant enzymes such as SOD 
and GPx were found to be significantly decreased in 
alcohol-treated rats compared to the control group. 
The researchers concluded that administration of EFE 
at a dose of 250 mg/kg body weight/day to alcohol-
treated rats offers protection by simultaneously 
lowering the carbonyl content and lipid peroxidation 
and elevating antioxidant enzyme activities.
In another study by Gopumadhavan,[47] 12–
14 weeks old Wistar male rats weighing between 
300 and 350 g were used. The rats were divided 
randomly into four groups of ten each.
• Group 1: Was the control group and received 
only the fish oil at a dose of 2.5 ml/kg/day
• Group 2: Was the ethanol-treated group, 
which received ethanol at a dose of 6 g/kg/day 
for 1st week along with 2.5 ml/kg of fish oil
• Rats of Groups 3 and 4: Were PartySmart 
(aqueous extract of Phoenix dactylifera [188 mg], 
Cichorium intybus [188 mg], Andrographis 
paniculata [188 mg], Vitis vinifera [188 mg], 
Phyllanthus amarus [124 mg], and EO [124 mg]) 
treated group and were received PartySmart 
as aqueous suspension at a dose of 250 and 
500 mg/kg body weight/day, respectively.
The animals in all the groups were treated for 
8 days orally. At the end of the treatment, they 
took blood and determined the levels of ALT, 
AST, and ALP. A portion of the liver was fixed in 
10% neutral buffered formalin and processed for 
histopathological evaluation using hematoxylin and 
eosin. The values were expressed as mean ± SE and 
analyzed statistically using one-way ANOVA to find 
out the level of significance. The minimum level of 
significance was fixed at P < 0.05.
In this study, it was found that the administration 
of ethanol increases oxidative stress as manifested 
by a significant raise in the levels of ALT, AST, 
and ALP. They observed the changes found to 
be significant at 500 mg/kg body weight dose of 
PartySmart treatment. The researchers concluded 
that the administration of PartySmart in alcohol-
induced oxidative stressed rats, increased the 
levels of serum parameters, involves in the 
prevention of cell membrane disturbance and 
reduction of oxidation stress by free radical 
scavenging and antioxidant activity. Further, 
they remind detailed studies on the liver are 
warranted to elucidate the precise mechanism of 
action. Liver section from rat treated suspension 
of PartySmart and ethanol-intoxicated with 
PartySmart and ethanol intoxicated group showed 
lesser vacuolar degeneration.[47] Rats showing 
marked improvement in glycogen.[47]
Amelioration of alcohol-induced oxidative stress by 
EO also was studied by Reddy.[48] Two-month-old 
male albino Wistar rats, weighing about 120–140 g 
were used. The rats were divided randomly into 
four groups of eight rats in each group.
• Group I: Was the control group and received 
glucose instead of alcohol (i.e., caloric 
equivalent to alcohol)
• Group II: Was the alcohol-treated group, which 
received 20% (v/v) alcohol at a dose of 5 g/kg 
body weight/day
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• Group III: Was the alcohol plus EFE treated rats 
received aqueous EFE (AEFE) and was given 
20% (v/v) alcohol (at a dose of 5 g/kg body 
weight/day plus AEFE, at a dose of 250 mg/kg 
body weight/day
• Group IV: Animals in this group received only 
the AEFE, at a dose of 250 mg/kg body weight 
daily.
The animals in all the groups were treated for 
60 days by gastric intubations. The food and water 
intake recorded daily and weight of rats was followed 
on alternate days. At the end of the experimental 
period, they took blood and determined the levels 
of serum total protein, albumin to globulin (A/G) 
ratio, total bilirubin, creatinine, uric acid, and nitric 
oxide using commercial kits. Mean and SD values of 
all the parameters were determined for each group. 
The data were subjected to ANOVA. The level of 
significance was P < 0.05. Administration of EFE 
to alcohol-treated rats significantly decreased the 
levels of total bilirubin, creatinine, and nitric oxide, 
and increased the levels of plasma uric acid, total 
protein and A/G ratio when compared to alcohol 
alone treated group. The investigators explained 
that the toxicity is due to lipid peroxidation caused 
by the free radical generated in the form of ROS and 
inhibition of lipid peroxidation by EO ameliorates 
alcohol-induced oxidative stress. The researchers 
concluded that administration of EO plays a role in 
protecting hepatic, as well as renal function. The 
amelioration of alcohol-induced oxidative stress by 
EFE due to the polyphenols compounds.
In another study by Krushna,[49] the protective 
effect of EO was investigated in the prevention 
of alcohol-induced biochemical changes. Two-
month-old male albino Wistar rats, weighing about 
120–140 g were used. The animals were divided 
randomly into four groups each having eight 
members.
• Group I: Was the control group and received 
isocaloric amounts of glucose equal that of 
alcohol
• Group II: Was the alcohol-treated group, which 
received 33% (v/v) alcohol at a dose of 10 g/kg 
of body weight/day
• Group III: Was the alcohol plus AEFE treated 
group and was given 33% (v/v) alcohol (at a 
dose of 10 g/kg of body weight/day) plus EFE, 
at a dose of 250 mg/kg of body weight/day
• Group IV: Animals in this group received only the 
AEFE, at dose of 250 mg/kg of body weight/day.
The animals in all the groups were treated orally 
for 60 days. At the end the treatment, blood was 
collected and determined the activities of AST, 
ALT, ALP, and lactate dehydrogenase (LDH) using 
commercial kits. The statistical significance of the 
difference between control and treatment groups 
in this study was determined by ANOVA. The data 
were expressed as mean and SD. The level of 
significance chosen was P < 0.05.
The investigators explained the adverse effect 
of chronic alcohol feeding resulted in higher 
activities of the alcoholic plasma marker enzyme 
gamma-glutamyl transferase and abnormalities in 
plasma lipid and lipoproteins, as well as activities 
of plasma transaminases (AST and ALT), ALP, and 
LDH. Chronic alcohol administration significantly 
decreased the activities of SOD, CAT, and GPx with 
a fall in GSH content in erythrocytes activities. 
The AEFE supplementation to chronically alcohol-
fed rats beneficially modulated plasma lipids and 
lipoprotein patterns and also corrected plasma 
enzyme activities and improved antioxidant and 
defense enzyme machinery status.
The researchers concluded that AEFE 
supplementation resulted in a significant increase 
in GSH content and the activities of SOD, CAT, 
and GPx. AEFE can contribute to the alleviation of 
alcohol-induced adverse effects by enhancing the 
status of the antioxidant defense system and by 
regulating lipid and mineral metabolism.
Discussion
In all of the researches conducted by various 
investigators confirm edit was that alcohol-induced 
oxidative stress caused damage of different organs 
and resulted in significant changes in all serum 
parameters, such as TBARS, nitrite/nitrates, and 
antioxidant enzymes. The parameters measured by 
the researchers were serum AST, ALT, and ALP and 
antioxidant enzymes SOD, CAT, and GPx.
In the investigation by Damodara Reddy,[44] 
alcohol treatment at a dose of 5 g/kg body weight 
administered by gastric intubation for 60 days resulted 
in increase in TBARS from 1.31 ± 0.18 nmole/mg (in 
the control) to 2.81 ± 0.29 nmole/mg (in the alcohol-
treated) and nitrite/nitrates from 3.42 ± 0.21 nmole/
mg (in the control) to 6.62 ± 0.53 nmole/mg (in the 
alcohol-treated). Coadministration of EO at dose of 
250 mg/kg/day for 60 days decreased the changes 
TBARS and nitrite/nitrates to 1.7 ± 0.22 nmole/mg and 
3.7 ± 0.34 nmole/mg, respectively, and also alcohol 
treatment caused CAT, SOD, and GPx decreased 
from 39.64 ± 1.17 U/mg, 22.02 ± 1.46 U/mg, and 
9.44 ± 0.92 mole/mg (in the control) to 26.02 ± 2.51 U/
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mg, 14.14 ± 1.57 U/mg, and 4.41 ± 0.51 U/mg (in the 
alcohol-treated) respectively. Coadministration of 
EO elevated the change to 35.11 ± 1.35 U/mg, 21.27 
± 1.07 U/mg, and 8.58 ± 0.56 U/mg, respectively. 
In this study, there were changes that occurred in 
the alcohol-treated group is because the increased 
formation of lipid peroxides and associated ROS 
leads to liver damage. Moreover, the administration 
of EFE used in alcohol-induced oxidative stress rats 
increases the activity of enzymatic antioxidants; 
inhibits the effect of lipid peroxidation by its 
free radical scavenging nature and improves the 
histomorphology of the liver to the normal.
In the study conducted by Yokozawa,[45] 
supplementation of animals with amla after treated 
with alcohol, resulted in amelioration of adverse 
effects of alcohol. For example, the level of lipids 
such as cholesterol and TAG were increased in 
serum and liver in aged rats as compared to the 
young rats. Administration of amla for 100 days to 
aged rats attenuates age-related dyslipidemia and 
oxidative stress by inhibiting increases in cholesterol 
and TAG levels in the serum and liver.
In the study conducted by Reddy,[46] administration 
of alcohol 33% (v/v) at a dose of 10 g/kg of body 
weight/day for 60 days caused AST to rise from 
26.53 ± 3.16 IU/L (in the control) to 78.02 ± 
6.31 IU/L (in the alcohol-treated). Coadministration 
of EFE 250 mg/kg of body weight/day decreased 
the change to 25.58 ± 3.67 IU/L, and ALT 
(26.30 ± 3.84 IU/L), (84.02 ± 11.38 IU/L), and (26.58 ± 
3.67 IU/L), respectively, whereas alcohol treatment 
at dose of 10 g/kg for 60 days caused to lower SOD, 
GPx from 9.62 ± 0.12 IU/mg and 3.05 ± 0.20 mole 
(in the control) to 6.24 ± 0.16 IU/mg and 1.72 ± 
0.22 mole (in the alcohol-treated). Administration 
of EFE at a dose of 250 mg/kg for 60 days raises the 
change to 9.68 ± 0.15 IU/L and 3.08 ± 0.13 mole/mg, 
respectively. The change seen in the administration 
of EFE at the dose of 250 mg/kg for 60 days can 
preserve the structural integrity of the liver from 
the adverse effects of ethanol.
In addition, the administration of ethanol at a dose 
of 6 mg/kg daily for 8 days in study of Krushna 
et al.,[49] caused AST, ALT, and ALP to raise from 
119.60 ± 7.97 IU/L, 67.67 ± 2.85 IU/L, and 220.30 
± 14.2 IU/L (in the control) to 150.90 ± 8.43 IU/L, 
86.5 ± 7.07 IU/L, and 319.20 ± 21.67 IU/L (in the 
ethanol-treated), respectively. Coadministration of 
polyherbal formulation PartySmart at the dose of 
250 mg/kg and 500 mg/kg daily for 8 days decreased 
the changes to AST (135.50 ± 7.07 IU/L and 121.30 
± 5.01 IU/L), ALT (70.25 ± 3.91 IU/L and 7.50 ± 
2.18 IU/L), and ALP (274.30 ± 22.7 IU/L and 243.00 
± 13.34 IU/L), respectively. The changes found to 
be significant at dose of 500 mg/kg body weight/
day PartySmart treatment. When we compare 
these researches, the administration of PartySmart 
in the study of Gopumadhavan et al.[47] caused the 
decrease of the values closest to the normal level as 
compared to the study of Reddy et al. (2009). These 
may be the high dose of PartySmart, 500 mg/kg and 
lower dose of ethanol 6 g/kg for 8 days treatment, 
whereas in the study of Reddy et al.,[46] the lower 
dose of EO, 250 mg/kg as compared to Nandi et al.[13] 
and high dose alcohol, 10 g/kg.
In the study conducted by Reddy,[48] supplementation 
of animals with amla after treated with alcohol, 
resulted in amelioration of adverse effects of alcohol. 
For example, the levels of total bilirubin, creatinine, 
and nitric oxide increased from 0.61 ± 0.03 mg/dl, 
0.84 ± 0.02 mg/dl, and 27.29 ± 1.93 µmole/L (in the 
control) to 1.02 ± 0.06 mg/dl, 0.81 ± 0.06 mg/dl, and 
43.44 ± 3.37 µmole/L (in the alcohol treated), and 
decreased in uric acid, total protein, and A/G ratio 
from 2.46 ± 0.14 mg/dl, 6.92 ± 0.29 g/dl, and 1.48 
± 0.07 (in the control) to 1.72 ± 0.15 mg/dl, 5.77 ± 
0.41 g/dl, and 1.13 ± 0.06 (in the alcohol-treated), 
respectively. Administration of 250 mg/kg EFE to 
alcohol-treated rats significantly decreased the 
levels of total bilirubin, creatinine, and nitric oxide 
from 1.02 ± 0.06 mg/dl, 0.81 ± 0.06 mg/dl, and 
43.44 ± 3.37 µmole/L (in the alcohol treated) to 0.64 
± 0.07 mg/dl, 0.46 ± 0.05 mg/dl, and 27.0 ± 32.24 
µmole/L (in the EFE treated), and raised the levels 
of uric acid, total protein and A/G ratio from 1.77 ± 
0.15 mg/dl, 5.77 ± 0.41 g/dl, and 1.13 ± 0.06 (in the 
alcohol-treated) to 2.51 ± 0.11 mg/dl, 6.98 ± 0.43 g/
dl, and 1.51 ± 0.083 (in the EFE treated), respectively. 
This is because of inhibition of lipid peroxidation by 
EO ameliorates alcohol-induced oxidation stress.
Histological section of the liver in majority of the 
investigators has similar results[44] and has stated 
that histologically the liver of alcohol treated rats 
showed fibrosis, atrophy and nucleus is degenerated. 
The same thing is said by Gopumadhavan[47] that in 
the histological study animals treated with ethanol 
(6 g/kgb.wt/day) showed ballooning of hepatocytes 
with vacuolar degeneration, necrosis, and flattened 
nuclei in the hepatic sinusoids. This effect was 
significantly decreased in animals treated with amla 
in both studies. EO treatment markedly ameliorates 
the severity of hepatic alternations.
In all of the studies by different investigators albino 
Wistar rats were used. In majority of the studies, 
2-month-old rats weighing 120–140 g were used, 
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except in the study conducted by Gopumadhavan,[47] 
12–14 weeks old weighing 300–350 g and,[49] 
2 months old weighing 125 g and 10 months old 
weighing 476 g were used. The rats were randomly 
divided into different groups in all studies except in.[45]
In the study conducted by Damodara Reddy[44] and 
Reddy[48] 20% (v/v) alcohol at a dose of 5 g/kg body 
weight/day was used and 33% (v/v) alcohol at a dose 
of 10 g/kg body weight/day was used in the study of 
Krushna et al.[49] and Reddy et al.[46] However, in the 
study of Gopumadhavan et al.[47] and Yokozawa et 
al.,[45] alcohol at a dose of 6 g/kg body weight/day and 
10 mg/kg body weight/day were used, respectively. 
In all of the studies, EFE was used at the same 
dose of 250 mg/kg body weight/day, except in the 
study of Yokozawa et al.,[45] the extract used at a 
dose of 40 mg/kg body weight/day. The animals in 
majority of studies were treated for 60 days, except 
in Gopumadhavan et al.[47] and Yokozawa et al.,[45] 
treated for 8 and 100 days, respectively. The alcohol 
and extract were administered in majority of studies 
by gastric intubations, whereas, in Krushna et al.,[49] 
administered orally. However, different methods 
were used by different researchers and the levels 
of different parameters were determined using 
different techniques, in all of the studies by different 
investigators the same results were obtained.
Conclusion
In all studies, the toxicity of alcohol is confirmed, 
so avoidance of unnecessary exposure has to be 
considered. Ethanol-induced oxidative stress is the 
result of the combined impairment of antioxidant 
defenses and the production of ROS. As clearly 
established by the various researches, EO ameliorates 
the toxic effect of the alcohol on liver and other 
organs by lowering free radical-mediated oxidative 
stress. Ongoing research should provide additional 
insight into the biological mechanisms underlying 
liver and other organ damage and new approaches 
to treating the problem in alcoholic patients.
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